Rynd Urine Bladder Cancer Recurrence Test
Bladder Cancer Recurrence Monitoring
Phase 2Active
Key Facts
About Rynd Biotech
Fast, painless urine test for bladder cancer recurrence using a patented 4‑biomarker panel.
View full company profileTherapeutic Areas
Other Bladder Cancer Recurrence Monitoring Drugs
| Drug | Company | Phase |
|---|---|---|
| Octosense for Bladder Cancer | Cellens | Pre-clinical/Clinical Validation |